PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Net Income

Annual figures by fiscal year, from SEC filings.

2003: -$3.16M2004: -$4.34M2005: -$11.76M2006: -$8.87M2007: -$10.01M2008: -$10.27M2009: -$12.32M2010: -$18.55M2011: -$19.43M2012: -$12.57M2013: -$27.70M2014: -$10.24M2015: -$24.50M2016: -$24.43M2017: -$13.52M2018: -$8.15M2019: -$6.92M2020: -$6.68M2021: -$5.54M2022: -$3.55M2023: -$3.10M2024: -$4.73M2025: -$5.43M-$5.43M
2003Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$5.43M-14.8%
2024-$4.73M-52.6%
2023-$3.10M+12.7%
2022-$3.55M+35.8%
2021-$5.54M+17.0%
2020-$6.68M+3.5%
2019-$6.92M+15.1%
2018-$8.15M+39.7%
2017-$13.52M+44.7%
2016-$24.43M+0.3%
2015-$24.50M-139.2%
2014-$10.24M+63.0%
2013-$27.70M-120.4%
2012-$12.57M+35.3%
2011-$19.43M-4.8%
2010-$18.55M-50.6%
2009-$12.32M-20.0%
2008-$10.27M-2.6%
2007-$10.01M-12.8%
2006-$8.87M+24.6%
2005-$11.76M-170.8%
2004-$4.34M-37.7%
2003-$3.16M